Year: 2023

Küleon Bioscience Announces Scientific Breakthrough with First Known ”Trifunctional” 5-HT2C Receptor Agonist that is also a Full Antagonist of the 5-HT2A and 5-HT2B Receptors, Creating an Exciting Lead for Multiple Neuropsychiatric Illnesses

Aditxt, Inc. Announces Appointment of Ernie Lee as CEO of its Wholly-Owned Subsidiary, Pearsanta, to Lead Launch of Test2Treat.me Platform

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc., (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation activation company focused on the discovery,...

AQuity Solutions Ranked #1 for Virtual Scribes, Medical Transcription and Document Capture Solutions for 10th Consecutive Year by Black Book Poll

CHICAGO, IL / ACCESSWIRE / October 5, 2023 / Black Book™, recognized for accurate, impartial customer satisfaction surveys in the...

error: Content is protected !!